Catalyst Biosciences, Inc. (CBIO) Social Stream
Catalyst Biosciences Inc (CBIO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CBIO.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
CBIO's average price target has moved down $6.33 over the prior 161 days.
Over the past 161 days, CBIO's average upside potential has been 316.8%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CBIO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 52 weeks, CBIO's average broker recommendation rating worsened by 0.17.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Catalyst Biosciences Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 399.13% of that group.
- To contextualize these metrics, consider that out of all US stocks, Catalyst Biosciences Inc's variance in analysts' estimates is lower than -116.38% of them.
- Catalyst Biosciences Inc's average analyst price target is higher than 87.24% of Healthcare stocks.
- Catalyst Biosciences Inc's number of analysts covering the stock is greater than 91.92% of Pharmaceutical Products stocks.
What is the outlook for CBIO? Use POWR Ratings for clearer insight into price direction.